Stage I/II Nasal NK Cell Lymphoma

NCT01321008 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Lymphoma

Interventions

RADIATION: Radiation
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center